Home › Funds › CANTOR FITZGERALD, L. P. › MRNA
CANTOR FITZGERALD, L. P. position in MRNA
MODERNA INC · Health Care
CANTOR FITZGERALD, L. P. reported holding 51,644 shares of MRNA (MODERNA INC) in its Q3 2026 13F filing — a position valued at US$9.9M, representing 0.32% of its reported portfolio and ranking #43 among its reported holdings. CANTOR FITZGERALD, L. P. has disclosed MRNA holdings in 9 of the last 12 reported quarters, going back to Q4 2023.
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
How CANTOR FITZGERALD, L. P.'s MRNA position evolved
CANTOR FITZGERALD, L. P. first disclosed a stake in MRNA in Q4 2023 at 200 shares (US$498K). The position peaked in Q3 2026 at 51,644 shares, worth US$9.9M. Across 9 filings, CANTOR FITZGERALD, L. P. increased the stake 3 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 51,644 shares valued at US$9.9M — an increase of 28,872 shares quarter over quarter.. Notable position changes include a 455% increase in Q1 2025 (shares fell 3% over the following quarter), a 128% increase in Q2 2026 (shares rose 175% over the following quarter), a 127% increase in Q3 2026 (shares rose 12% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2023 | 200 | $497.80K | New |
| Q2 2024 | 25.00K | $540.87K | New |
| Q4 2024 | 16.96K | $705.24K | New |
| Q1 2025 | 94.14K | $2.67M | Add |
| Q2 2025 | 59.59K | $1.64M | Reduce |
| Q3 2025 | 59.28K | $1.53M | Reduce |
| Q1 2026 | 10.01K | $508.46K | New |
| Q2 2026 | 22.77K | $1.59M | Add |
| Q3 2026 | 51.64K | $9.95M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About MRNA and 13F data
MRNA (MODERNA INC) is a Health Care company. 47 other funds we track also report a position in MRNA — the largest reported positions include Fidelity Management & Research (FMR) (US$11.35B), Capital World Investors (US$4.36B), Baillie Gifford & Co (US$2.20B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding MRNA
- Fidelity Management & Research (FMR) 58.96M sh · $11.35B · Q3 2026
- Capital World Investors 22.64M sh · $4.36B · Q3 2026
- Baillie Gifford & Co 11.44M sh · $2.20B · Q3 2026
- Theleme Partners LLP 6.66M sh · $1.28B · Q3 2026
- Flagship Pioneering, LLC 4.63M sh · $892.01M · Q3 2026
- IMC-Chicago, LLC 3.07M sh · $590.92M · Q3 2026
- SUSQUEHANNA INTERNATIONAL GROUP, LLP 2.42M sh · $466.58M · Q3 2026
- Merck & Co., Inc. 2.31M sh · $444.49M · Q3 2026
- BANQUE PICTET & CIE SA 2.15M sh · $414.27M · Q3 2026
- a16z Perennial Management, L.P. 1.52M sh · $292.57M · Q3 2026
- PERCEPTIVE ADVISORS LLC 1.40M sh · $269.60M · Q3 2026
- BAMCO INC /NY/ 1.39M sh · $267.88M · Q3 2026
More on CANTOR FITZGERALD, L. P.
FAQ
How long has CANTOR FITZGERALD, L. P. held MRNA?
CANTOR FITZGERALD, L. P. has disclosed MRNA holdings in 9 of the last 12 reported quarters, going back to Q4 2023.
What is CANTOR FITZGERALD, L. P.'s current position in MRNA?
As of Q3 2026, CANTOR FITZGERALD, L. P. holds 51.64K shares of MRNA (MODERNA INC), valued at $9.95M, representing 0.32% of its reported portfolio and ranking #43.
Has CANTOR FITZGERALD, L. P. been buying or selling MRNA?
In the latest 13F filing (Q3 2026), CANTOR FITZGERALD, L. P. increased its position in MRNA. The position peaked in Q3 2026 at 51.64K shares.
Which other funds hold MRNA?
Other major institutional holders of MRNA include Fidelity Management & Research (FMR), Capital World Investors, Baillie Gifford & Co, among 47 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.